|
Modifier text |
What it means |
|---|---|
| Directed |
This component has been collected from a selected donor known to the patient, usually a close relative of the patient. It is reserved for that patient and will come with a blue label specifying that patient’s details. Such components are always irradiated. |
| Hyper concentrated | The supernatant has been removed from the red cell component and the expiry reduced to 48 hours post-hyper concentration. |
|
Irradiated |
The component has been irradiated and the expiry has been reduced accordingly. It will have a RAD–SURE® label to indicate that irradiation was performed. |
|
Irradiated NEONATAL |
The component has been ordered for a neonatal transfusion and has been irradiated. The expiry has been reduced to 48 hours post-irradiation. It will have a RAD–SURE® label to indicate that irradiation was performed. |
| Irradiated for IUT |
The component has been ordered for an intrauterine transfusion and has been irradiated. The expiry is reduced to 24 hours post-irradiation. |
|
Hyper concentrated/irradiated |
The supernatant has been removed and the component has been irradiated. The expiry is reduced to 24 hours post-hyperconcentration or irradiation. |
|
For intrauterine transfusion |
The component has been ordered for an intrauterine transfusion. The expiry has been reduced to 48 hours post-application of the modifier (eg, washing). |
|
The originating donor sample/donation has been tested for CMV antibody and is negative. |
|
|
Not NAT tested |
This component has been released without NAT testing being performed, usually due to extenuating circumstances such as machine failure or specific clinical demand. A disclaimer form will accompany these components. |
|
The originating donor sample/donation has been tested and anti-T was not detected. |
|
|
IgA deficient |
The originating donor sample/donation has been tested and is IgA deficient. |
|
The component is from a Le (a-b+) donor and, as such, is suitable for absorption of Lewis antibodies. Suitable for transfusion. |
|
|
Not for neonatal use |
The component has been deemed unsuitable for neonatal use due to the presence of red cell antibodies (low titre only). It should not be transfused to a neonate. |
|
The originating donor sample/donation or previous testing of donor has had an extended phenotype performed and forms part of a panel of cells reserved for patients with antibodies or where antigen negative blood is otherwise specifically required. |
|
|
The originating donor sample/donation has low levels of anti-A and anti-B. |
|
|
Autol release - see disclaimer |
This autologous component has tested positive for one or more viral markers but has been released upon request by the patient’s physician. A disclaimer form will accompany these components. |
| Notes: NAT: nucleic acid technology; CMV: cytomegalovirus; IUT: intrauterine transfusion | |